Remedy System - Osteoremedies

1y ago
8 Views
2 Downloads
2.63 MB
12 Pages
Last View : 4d ago
Last Download : 3m ago
Upload by : Warren Adams
Transcription

REMEDY SHOULDER SYSTEM SHOULDER MODULARITY The REMEDY Shoulder Spacer is part of the treatment foreseen in a two-stage procedure performed in the event of permanent prosthesis infection. The REMEDY Shoulder Spacer implant is intended for temporary use only (180 days or less). It allows basic joint mobility and releases antibiotics into the joint area to protect the implant from bacterial colonization. A second surgery will be required at a later date to remove the REMEDY Shoulder Spacer and replace it with a permanent shoulder joint implant. REMEDY MODULAR STEMS REMEDY Shoulder Spacers: Single-use medical devices/ethylene oxide sterile 50mm Formed with bone cement (PMMA) and gentamicin Large Stem Stainless steel rod reinforces the humeral stem 45mm REMEDY MODULAR HEADS Medium Stem Head sizes interchangeable with stems for surgical flexibility 40mm Small Stem u Variable head and neck design allows desired placement and positioning up to 9mm 2 u u Stainless steel rods within stems provide added mechanical strength

REMEDY HIP SYSTEM HIP MODULARITY REMEDY MODULAR STEMS The REMEDY Hip Spacer is part of the treatment foreseen in a two-stage procedure performed in the event of permanent prosthesis infection. The REMEDY Hip Spacer implant is intended for temporary use only (180 days or less). It allows basic joint mobility Long Stem Large and releases antibiotics into the joint area to protect the implant from bacterial colonization. A second surgery will be required at a later date to remove the REMEDY Hip Spacer and replace it with a permanent hip joint implant. Long Stem Medium REMEDY Hip Spacers: Single-use medical devices/ethylene oxide sterile Long Stem Small Formed with bone cement (PMMA) and gentamicin Short Stem Large Stainless steel rod reinforces the femoral stem Short Stem Medium Short Stem Small u u u Stainless steel rods within stems provide added mechanical strength Variable head and neck design allows desired placement and positioning up to 17mm 60mm REMEDY MODULAR HEADS Head sizes interchangeable with stems for surgical flexibility 54mm 46mm 3

REMEDY KNEE SYSTEM KNEE INTERCHANGEABILITY The REMEDY Knee Spacer is part of the treatment foreseen in a two-stage L REMEDY LARGE MODULAR KNEE procedure performed in the event of permanent prosthesis infection. The REMEDY Knee Spacer implant is intended for temporary use only (180 days or less). It allows basic joint mobility and releases antibiotics into the joint area to protect the implant from bacterial colonization. A second surgery will be Femoral Component 74mm (Large) Tibial Component 80mm (Large) required at a later date to remove the REMEDY Knee Spacer and replace it with a permanent knee joint implant. REMEDY Knee Spacers: Single-use medical devices/ethylene oxide sterile Formed with bone cement (PMMA) and gentamicin TOTAL SYSTEM INTERCHANGEABILITY 65% of cases result in different size femur and tibia* 35% of cases use a tibial wedge* Tibial Wedge 80mm - Width 10mm - Height (Large) M L L M S M S M M L S L S S S L M L M S REMEDY MEDIUM MODULAR KNEE Femoral Component 64mm (Medium) Tibial Component 70mm (Medium) Tibial Wedge 70mm - Width 10mm - Height (Medium) REMEDY SMALL MODULAR KNEE Femoral Component 54mm (Small) Tibial Component 60mm (Small) Tibial Wedge 60mm - Width 10mm - Height (Small) Size XL Femoral Component also available upon request 4 * Internal OsteoRemedies data

REMEDY ELUTION PROFILE OF ANTIBIOTICS ANTIBIOTIC TREATMENT PLAN 1 Antibiotics In Spacers: REMEDY Spacers – 4.8% Gentamicin In Sulfate Molds – Various/Inconsistent 2 Antibiotics In Cement For Fixation Same With Molds Or REMEDY Spacer System 3 Systemic Antibiotic Treatment Plan Same With Molds Or REMEDY Spacer System ELUTION OVERVIEW REMEDY data supported by third-party analysis and referenced in available testing report 205 mg/7.2% AB Release 200 Data of Palacos R G and Simplex P Tobramycin are taken from: Moojen et al., 2008 - J. Arthroplasty TM 180 Palacos is a registered trademark of Heraeus Medical GmbH 160 REMEDY 150 mg/8.5% AB Release 140 Simplex P Tobramycin is a trademark of Stryker 120 100 80 60 40 27 mg/2.1% AB Release Intra-Op Molds 20 24 mg/0.9% AB Release 0 1 2 3 4 5 Weeks 6 7 8 9 6 Months REMEDY Hip w/ Long Stem (54mm Head) REMEDY Hip With Short Stem (54mm Head) REMEDY Knee w/ Medium Femur, Tibia, Insert Simplex P Tobramycin (51mm Head) Palacos R G (51mm Head) 5

REMEDY SHOULDER SPACER TECHNIQUE STEP 1 STEP 2 In accordance with the existing shoulder manufacturer’s technique, prepare the infected joint space by first removing the shoulder prosthesis and any PMMA cement, if present, and any hardware that may be a reservoir of infection. Using the Shoulder Spacer Trials and templates, select the appropriate size humeral stem and humeral head components. STEP 3 TRIAL Once the appropriate humeral head size is selected, open the package and remove the monomer vial. SHOULDER SPACER RSSLG Carefully, break the vial open and pour all the monomer into the screw opening of the humeral head. Continue to prepare the joint space with aggressive debridement, pulse lavage and other standard practices for preparing the infected joint space. 6800 Poplar Avenue Suite 120 Memphis, TN 38138 901.453.3141 info@osteoremedies.com OsteoRemedies.com OsteoRemedies and corporate mark are registered trademarks of OsteoRemedies, LLC 2015 RSSLG 11/15 TEMPLATE Insert and seal the hole with the plastic cover cap supplied with the humeral head. Shake the head for 60 seconds to ensure all of the threads within the head are wet with monomer. COVER CAP STEP 4 Remove the plastic cap, pour the remaining monomer out and place the head on the humeral stem. Begin turning the head until the desired offset and length are achieved. Approximate working time for the head is 10 to 15 minutes. Important Note: Once the head location is selected, be sure not to continue to adjust the head location as this could affect the fixation between the head and the stem. STEP 5 WARNING: The humeral head must be seated past the Safety Line marked in purple on the stem thread. On the stem trials, the purple line is designated with a missing thread on the stem trunnion. 6 Using UNITE AB Bone Cement, or other FDAcleared PMMA, apply cement to the proximal aspect of the stem. The use of bone cement is compulsory to avoid rotation and to limit the risk of dislocation or spacer loosening. Note: Bone cement may also be applied once the stem is seated within the humeral canal. STEP 6 Insert the humeral stem (with head properly affixed) into the canal to the desired position.

SHOULDER SPECIFICATIONS 2 7 1 8 5 6 REMEDY MODULAR HUMERAL HEAD REMEDY MODULAR HUMERAL STEM 3 4 REMEDY SHOULDER SPACER (MM) Gentamicin Base (g) Catalog # 1 2 REMEDY Modular Humeral Head 40mm RSHHSM 40 25 0.5 REMEDY Modular Humeral Head 45mm RSHHMD 45 25 0.5 REMEDY Modular Humeral Head 50mm RSHHLG 50 25 0.6 REMEDY Modular Humeral Stem - Small RSHSSM 101 7 9.4 7 19 9 0.1 REMEDY Modular Humeral Stem - Medium RSHSMD 116 10.5 12.6 10.5 19 9 0.3 REMEDY Modular Humeral Stem - Large RSHSLG 131 14 15.8 14 19 9 0.5 Description 3 4 5 6 7 8 7

REMEDY HIP SPACER TECHNIQUE STEP 1 STEP 2 In accordance with the existing total joint manufacturer’s technique, prepare the infected joint space by first removing the prosthesis and any PMMA cement, if present, and any hardware (which may be a reservoir of infection). Using the REMEDY Spacer Trials and templates, select the appropriate size femoral stem and femoral head components. STEP 3 TRIALS Once the appropriate head size is selected, open the package and remove the monomer vial. TEMPLATE Break the vial open and pour all the monomer into the screw opening of the head. STEP 4 Insert and seal the hole with the plastic cover cap supplied. Shake the head for 60 seconds to ensure all of the threads within the head are wet with monomer. Continue to prepare the joint space with aggressive debridement and pulse lavage. COVER CAP (Approximate working time for head position is 10 to 15 minutes.) STEP 5 Remove the cover cap, pour the remaining monomer out and place head onto the femoral stem. Begin to turn the femoral head until the appropriate “off-set” is achieved. STEP 6 WARNING: The head must be seated past the Safety Line marked in blue or purple on the stem thread. On the Trials, the blue or purple line is designated Important Note: with a missing thread on Once the head location the trunnion. is selected, be sure not to continue to adjust the head location as this could affect the fixation between the head and the stem. 8 STEP 7 Using UNITE AB Bone Cement, or any FDAcleared AB PMMA, apply cement to the proximal aspect of the stem. The use of the cement is compulsory to avoid rotation and to limit the risk of dislocation. Note: Cement may also be applied once seated within the femoral canal. Insert the stem (with head properly affixed) into the canal.

HIP SPECIFICATIONS 7 1 2 REMEDY MODULAR HEAD 8 6 5 REMEDY MODULAR STEM 7 REMEDY MODULAR LONG STEM 3 6 8 5 3 4 4 REMEDY HIP SPACER Description (MM) 3 4 5 6 7 8 Gentamicin Base (g) Catalog # 1 2 REMEDY Modular Head 46mm RHHDSM 46 42.3 0.9 REMEDY Modular Head 54mm RHHDMD 54 50.9 1.6 REMEDY Modular Head 60mm RHHDLG 60 57.3 2.3 REMEDY Modular Stem - Small RHSTSM 111 10 16.5 11.3 35.6 17 0.5 REMEDY Modular Stem - Medium RHSTMD 112 11 21.7 15.5 35.6 17 0.6 REMEDY Modular Stem - Large RHSTLG 117 11.5 24 16.5 35.6 17 0.7 REMEDY Modular Long Stem - Small RHLSSM 227 10 16.5 11.3 35.6 17 0.6 REMEDY Modular Long Stem - Medium RHLSMD 227 11 21.7 15.5 35.6 17 0.8 REMEDY Modular Long Stem - Large RHLSLG 231 11.5 24 16.5 35.6 17 0.9 9

REMEDY KNEE SPACER TECHNIQUE TEMPLATE TRIALS STEP 1 In accordance with the existing total joint manufacturer’s technique, prepare the infected joint space by first removing the prosthesis and any PMMA cement, if present, and any hardware (which may be a reservoir of infection). Continue to prepare the joint space with aggressive debridement and pulse lavage. STEP 3 STEP 2 Using the REMEDY Spacer Trials and templates, select the appropriate size femoral and tibial components. It is important that the joint is neither loose nor tight, therefore the surgeon will have to consider the additional room occupied by the cement needed for the fixation. STEP 4 Using UNITE AB Bone Cement, or any FDA-cleared AB PMMA, apply cement over the entire surface of the component and tibial plateau and insert into the tibia. Apply PMMA bone cement (see Step 3) to the femoral component and femoral surface. STEP 5 Reduce the joint, removing all the excess cement, avoiding the cement that may go on the articular surface. To assure correct alignment of the components, make flex/extension movements before the cement curing occurs. Then close and check flex/extension movements and lateral stability. 10 OPTIONAL Depending on the stability of the knee, it may be necessary to apply a brace to avoid the risk of dislocation. If the tibial bone defect is excessive and additional height is required, apply PMMA to the tibial wedge/ insert and cement this to the inferior aspect of the tibial component. Note: When placing the components with cement, DO NOT impact the device with a mallet. It is recommended to use hand pressure only while placing the components.

KNEE SPECIFICATIONS 3 1 2 REMEDY FEMORAL COMPONENT 7 8 5 6 7 4 REMEDY TIBIAL 5 9 COMPONENT REMEDY TIBIAL WEDGE/ INSERT 4 REMEDY KNEE SPACER Description (MM) Catalog # 1 2 3 4 5 6 7 8 9 Gentamicin Base (g) REMEDY Tibial Component 60mm RKTBSM 60 36 25 14 7.8 0.4 REMEDY Tibial Component 70mm RKTBMD 70 42 25 14 8.2 0.6 REMEDY Tibial Component 80mm RKTBLG 80 48 25 14 8.8 0.9 REMEDY Femoral Component 54mm RKFMSM 54 41.6 9.5 0.5 REMEDY Femoral Component 64mm RKFMMD 64 49.3 10.5 0.8 REMEDY Femoral Component 74mm RKFMLG 74 56.3 11.5 1.2 REMEDY Femoral Component 84mm RKFMXL 84 63.4 12.5 1.6 REMEDY Tibial Wedge/Insert 60mm RKINSM 60 36 14.5 10 0.3 REMEDY Tibial Wedge/Insert 70mm RKINMD 70 42 14.5 10 0.5 REMEDY Tibial Wedge/Insert 80mm RKINLG 80 48 14.5 10 0.7 11

UNITE AB BONE CEMENT UNITE AB Bone Cement is a high-viscosity, radiopaque bone cement containing and releasing gentamicin sulphate for manual application. UNITE AB Bone Cement is a single-use, sterile medical device provided in doses of 40g. UNITE AB Bone Cement contains 1 gram of gentamicin per 40 gram dose versus 0.5 grams in Palacos R G. With a lower ratio of monomer to powder as compared to market leading bone cement mixtures, UNITE provides benefits such as: Specifically designed formulation to work effectively with REMEDY Spacers – Lower maximum temperature from the chemical reaction may reduce the risk to surrounding tissues. – Reduced toxicity for those handling the cement. Description Catalog # (G) UNITE40 40 – Reduced cement shrinkage may improve implant fixation. UNITE AB Bone Cement UNITE Cement Palacos R Gentamicin Product Mixing Waiting Working Setting Total 1g Gentamicin 0.5g Gentamicin UNITE Cement 60” 90” 4’ 3’ 9’30” Palacos R G 30” 30” 4’ 3’30” 8’30” Gentamicin in Powder 2.5% 1.25% Gentamicin in Resin 1.8% 0.84% OsteoRemedies, LLC 1-800-OSTEO-XL 6800 Poplar Avenue 901-453-3141 Approximate set time as tested at 74 F. Suite 120 Memphis, TN 38138 info@OsteoRemedies.com OsteoRemedies.com OsteoRemedies, REMEDY, UNITE and the corporate mark are registered trademarks of OsteoRemedies, LLC REMEDY and UNITE are manufactured for OsteoRemedies, LLC 2017 5-17-V9 Palacos is a registered trademark of Heraeus Medical GmbH

REMEDY Hip With Short Stem (54mm Head) REMEDY Intra-Op Molds 205 mg/7.2% AB Release 27 mg/2.1% AB Release 24 mg/0.9% AB Release 6 Months REMEDY Hip w/ Long Stem (54mm Head) Simplex P Tobramycin (51mm Head) 200 150 mg/8.5% AB Release REMEDY Knee w/ Medium Femur, Tibia, Insert REMEDY ELUTION PROFILE OF ANTIBIOTICS

Related Documents:

The BMC Remedy IT Service Management Suite includes: The BMC Remedy Service Desk solution, which includes the BMC Remedy Incident Management application and the BMC Remedy Problem Management application The BMC Remedy Asset Management application The BMC Remedy Change Management application, which also includes the BMC

The following Citrix Online software and BMC products must be installed and operating correctly prior to the integration: Remedy AR System 4.0.1, 5.0 or 6.0.1 or later Optional: Remedy Help Desk 4.0, 5.0 or later Optional: Remedy CSS: Customer Support 4.0, 5.0 or later Citrix Online Software GoToAssist 6.0 or later.

Before using Remedy Service Desk Connector, ensure that you meet the following prerequisites: Remedy Service Desk IT Service Management 7.0.03 with the latest Incident Management patch, "IT Service Manage ment Patch 008" is installed and configured. Remedy Service Desk web services are up and running. See Web Service Details

- examining and updating the forms used by the Helpdesk to communicate problems reported and routed through the system - updating forms in use - creating new forms - new user groups in the system (ODDL, OTC) . Help desk and former AUS into the Remedy system. 5 - Provide programming support for a web accessible link to the Remedy system

3. Remedy nourishes the skin with a unique blend of Olivamine , natural oils and emollients. This step does not require additional effort because every Remedy product delivers nourishment along with its primary application. To understand the Remedy Advanced Skin Care System is to understand the skin itself. First and foremost, the skin

HP OpenView HP OpenView Smart Plug-In for Remedy Action Request System integration version 02.80 includes the following features: Asynchronous, bi-directional data exchange between the OVO/Unix . Self monitoring of the HP OV SPI for Remedy via logfile encapsulation of the

No hardware or software is required, so your organization can be up and running in days. The GoToAssist advantage is comprised of the following: . This out-of-box integration supports Remedy Help Desk, Remedy Customer Support or any AR System application, enabling you to quickly deploy a seamless remote-support solution. How it works

Le fabricant et l’utilisateur d’un additif alimentaire sont tenus: a. de transmettre à l’OSAV toute nouvelle information scientifique ou techni-que susceptible d’influer sur l’évaluation de la sécurité de cet additif; et b. d’informer l’OSAV, sur demande, des usages de l’additif concerné. Art. 11 Modification des annexes L’OSAV adapte régulièrement les annexes de la .